Google, Meta Snapping Up Twitter Employees Ahead Of Elon Musk's Planned Takeover: Report
Hundreds of Twitter employees who left the company in months ahead of Elon Musk's takeover of the social media platform have moved to major tech companies like Google and Meta, according to a report. It is based on the analysis of LinkedIn data to see how many workers are leaving Twitter and where they go after they leave. The deadline for Mr Musk to buy Twitter is set for Friday to avoid a trial over the $44 billion contract that he admits is overpriced.
The analysis of the data has been done by research firm Punks & Pinstripes, which found that around 530 workers quit Twitter in the past three months or 90 days. It said that this is a 60 per cent increase when compared to the number of employees who left the company in the previous quarter.
The data showed that 30 per cent of these employees have been hired by Google or Meta. Others have gone to companies like Pinterest, LinkedIn, TikTok and Snap.
Punks & Pinstripes said that 50 employees left Twitter just this month as the odds of Mr Musk buying the company look increasingly higher.
Out of the 7,500 employees of Twitter, more than 1,100 left the company since January, when Mr Musk began acquiring stock in it, the data further showed.
"This data flips the script on the rumours that if Elon Musk takes over he will drastically reduce headcount. The reality is that Twitter's talent has options of where they can work and they are capitalising on those options," the report quotes Punks & Pinstripes CEO Greg Larkin as saying.
Earlier this year, Google and Meta announced hiring freezes, so it's unclear if the companies made exception for experienced Twitter employees. Both the tech companies have so far not reacted to these reports.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.